Asmari, Maryam, Sil dos Santos, Bruno and Patel, Bhaven (2020) An undergraduate study for the comparison of dissolution profiles using 3D printed PVA and commercial paracetamol tablets. Materials Highlights, 1 (1-2). pp. 22-25. ISSN 2666-4933
Three-dimensional printing (3DP) is an additive manufacturing process that can rapidly render 3D objects from computer aided design software by successively depositing polymeric materials layer by layer. A range of different 3D printing technologies are in current use, with the most prevalent methodology using Fused Deposition Modelling (FDM) technology due to a synergetic combination that merges economic and accuracy/resolution factors. In 2015, Spritam®, a solid pharmaceutical formulation which contains the anti-epileptic drug levetiracetam, became the first 3D printed medicine approved by the US Food and Drug Administration (FDA) leading to a raised interest in this type of technology so to revolutionise healthcare in the area of personalised medicines.
Available under License Creative Commons Attribution Non-commercial 4.0.
Download (325kB) | Preview
View Item |